OneSource Speci.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE013P01021
  • NSEID: ONESOURCE
  • BSEID: 544292
INR
1,671.30
-41.85 (-2.44%)
BSENSE

Jan 20

BSE+NSE Vol: 1.2 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039523,
    "name": "OneSource Speci.",
    "stock_name": "OneSource Speci.",
    "full_name": "OneSource Specialty Pharma Ltd",
    "name_url": "stocks-analysis/onesource-speci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,671.30",
    "chg": -41.85,
    "chgp": "-2.44%",
    "dir": -1,
    "prev_price": "1,713.15",
    "mcapval": "19,410.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544292,
    "symbol": "ONESOURCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE013P01021",
    "curr_date": "Jan 20",
    "curr_time": "",
    "bse_nse_vol": "1.2 lacs",
    "exc_status": "Active",
    "traded_date": "Jan 20, 2026",
    "traded_date_str": "2026 01 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/onesource-speci-10039523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for OneSource Specialty Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-onesource-specialty-pharma-ltd-3797134",
        "imagepath": "",
        "date": "2026-01-20 23:16:43",
        "description": "The next results date for OneSource Specialty Pharma Ltd is scheduled for January 23, 2026...."
      },
      {
        "title": "Why is OneSource Speci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onesource-speci-fallingrising-3722373",
        "imagepath": "",
        "date": "2025-11-22 01:38:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>The stock has been under pressure over the past week, registering a decline of 6.07%, in stark contrast to the Sensex, which gained 0.79% during the same period. Over the last month, the disparity widened further, with OneSource Specialty Pharma falling 11.84% while the Sensex rose by 0.95%. This divergence highlights the stock’s relative weakness amid a generally positive market environment. Year-to-date and longer-term returns for the stock are not available, but the Sensex’s gains of 9.08% YTD and 10.47% over one year provide a benchmark for comparison, underscoring the stock’s lagging performance.</p>\n<p><strong>Technical Indicators and Trading Activity</strong></p>\n<p>On the day of 21-Nov, the stock’s intraday low touched ₹1,59..."
      },
      {
        "title": "How has been the historical performance of OneSource Speci.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-onesource-speci-3695893",
        "imagepath": "",
        "date": "2025-11-13 00:44:25",
        "description": "Answer:\nThe historical performance of OneSource Speci. shows significant fluctuations in key financial metrics over the past four years, particularly from March 2022 to March 2025.\n\nBreakdown:\nOneSource Speci. experienced a dramatic increase in net sales, rising from 128.18 Cr in March 2022 to 1,444.85 Cr in March 2025. This surge in total operating income followed a similar trend, moving from 171.92 Cr in March 2024 to 1,444.85 Cr in March 2025. However, the company's total expenditure also escalated, reaching 978.34 Cr in March 2025, up from 260.16 Cr in March 2024. Despite the growth in revenue, the operating profit (PBDIT) improved to 483.98 Cr in March 2025 from a loss of 84.01 Cr in March 2024. Nevertheless, the company reported a profit before tax of -67.07 Cr in March 2025, an improvement from -365.70 Cr in March 2024. The profit after tax also showed a slight recovery, with a loss of -17.28 Cr in M..."
      },
      {
        "title": "Why is OneSource Speci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onesource-speci-fallingrising-3691458",
        "imagepath": "",
        "date": "2025-11-12 00:28:17",
        "description": "As of 11-Nov, OneSource Specialty Pharma Ltd is experiencing a decline in its stock price, currently at Rs 1,740.00, which reflects a decrease of Rs 50.9 or 2.84%. The stock opened with a gain of 2.17% today but subsequently fell, reaching an intraday low of Rs 1,737.65, indicating volatility within the trading session. The stock has underperformed its sector by 2.71% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 59.45% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, OneSource Specialty Pharma Ltd's performance over the past week shows a decline of 4.70%, while the benchmark Sensex has increased by 0...."
      }
    ],
    "total": 181,
    "sid": "10039523",
    "stock_news_url": "https://www.marketsmojo.com/news/onesource-specialty-pharma-10039523"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of The Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 For Approval Of Unaudited Financial Results Of The Company For The Quarter Ended December 31 2",
      "datetime": "19-Jan-2026",
      "details": "Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 inter alia to consider and approve Approval of unaudited financial results of the Company for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "19-Jan-2026",
      "details": "Investor earning call to discuss unaudited financial results of the Company for the quarter ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Corporate Action-Amalgamation/ Merger / Demerger",
      "datetime": "14-Jan-2026",
      "details": "Amalgamation of Stelis Pte Limited with OneSource Specialty Pte Limited wholly owned subsidiaries of OneSource Specialty Pharma Limited",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "23 Jan 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is OneSource Speci. falling/rising?

2025-11-22 01:38:49

Recent Price Movement and Market Comparison

The stock has been under pressure over the past week, registering a decline of 6.07%, in stark contrast to the Sensex, which gained 0.79% during the same period. Over the last month, the disparity widened further, with OneSource Specialty Pharma falling 11.84% while the Sensex rose by 0.95%. This divergence highlights the stock’s relative weakness amid a generally positive market environment. Year-to-date and longer-term returns for the stock are not available, but the Sensex’s gains of 9.08% YTD and 10.47% over one year provide a benchmark for comparison, underscoring the stock’s lagging performance.

Technical Indicators and Trading Activity

On the day of 21-Nov, the stock’s intraday low touched ₹1,59...

Read full news article
stock-recommendationAnnouncement

Board Meeting Intimation for Intimation Of The Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 For Approval Of Unaudited Financial Results Of The Company For The Quarter Ended December 31 2

19-Jan-2026 | Source : BSE

Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 inter alia to consider and approve Approval of unaudited financial results of the Company for the quarter ended December 31 2025.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

19-Jan-2026 | Source : BSE

Investor earning call to discuss unaudited financial results of the Company for the quarter ended December 31 2025

Corporate Action-Amalgamation/ Merger / Demerger

14-Jan-2026 | Source : BSE

Amalgamation of Stelis Pte Limited with OneSource Specialty Pte Limited wholly owned subsidiaries of OneSource Specialty Pharma Limited

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

23 Jan 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available